Professor Tim Elliott gave the 2026 Dr Stanley Ho Memorial Lecture, ‘Personalising Vaccines for Cancer Prevention’, at the University of Macau on 24th July 2026. Cancer vaccines hold promise not only as treatments for established cancer but also as tools to intercept cancer before it becomes invasive disease. In this lecture, Professor Tim Elliott will explore how advances in immunology are opening up a new era of personalised cancer prevention. The lecture will introduce the concept of preventative cancer vaccines designed for individuals with defined cancer predispositions or pre-cancerous lesions, and will consider both the opportunities they create – for genuinely intercepting cancer development – and the scientific, clinical and ethical challenges that must be overcome before such strategies can be used widely in practice.

Professor Tim Elliott gave the 2026 Dr Stanley Ho Memorial Lecture, ‘Personalising Vaccines for Cancer Prevention’, at the University of Macau on 24th July 2026. Cancer vaccines hold promise not only as treatments for established cancer but also as tools to intercept cancer before it becomes invasive disease. In this lecture, Professor Tim Elliott will explore how advances in immunology are opening up a new era of personalised cancer prevention. The lecture will introduce the concept of preventative cancer vaccines designed for individuals with defined cancer predispositions or pre-cancerous lesions, and will consider both the opportunities they create – for genuinely intercepting cancer development – and the scientific, clinical and ethical challenges that must be overcome before such strategies can be used widely in practice.

We were delighted that the 2026 CPM Annual Lecture was given by Professor Trish Greenhalgh; ‘Personalised medicine: a view from primary care’. This took place at the Maths Institute, University of Oxford on Tuesday 28th April 2026. Introduction from Professor Anneke Lucassen.

We were delighted that the 2026 CPM Annual Lecture was given by Professor Trish Greenhalgh; ‘Personalised medicine: a view from primary care’. This took place at the Maths Institute, University of Oxford on Tuesday 28th April 2026. Introduction from Professor Anneke Lucassen.

The Centre for Personalised Medicine were honoured to partner with our longstanding and loyal supporters the Dr Stanley Ho Medical Development Foundation as well as the Chinese University of Hong Kong and the Centre for Novostics for the 2025 Dr Stanley Ho Memorial Lecture on Friday 4th July at the Cho Yiu Conference Hall, The Chinese University of Hong Kong. The lecture marked the 20th anniversary of the Dr Stanley Ho Medical Development Foundation and celebrated The Power and Potential of Genetics to Improve Healthcare, featuring the distinguished Professor Sir Peter Donnelly FRS, FMedSci, Hon FIA. With a career marked by ground-breaking contributions to human disease research, Professor Donnelly has transformed our understanding of meiotic recombination and pioneered innovative statistical methods that continue to shape modern healthcare. His leadership in key genetics projects over the past two decades has driven major advances in the field, profoundly impacting healthcare systems and patient outcomes.

The Centre for Personalised Medicine were honoured to partner with our longstanding and loyal supporters the Dr Stanley Ho Medical Development Foundation as well as the Chinese University of Hong Kong and the Centre for Novostics for the 2025 Dr Stanley Ho Memorial Lecture on Friday 4th July at the Cho Yiu Conference Hall, The Chinese University of Hong Kong. The lecture marked the 20th anniversary of the Dr Stanley Ho Medical Development Foundation and celebrated The Power and Potential of Genetics to Improve Healthcare, featuring the distinguished Professor Sir Peter Donnelly FRS, FMedSci, Hon FIA. With a career marked by ground-breaking contributions to human disease research, Professor Donnelly has transformed our understanding of meiotic recombination and pioneered innovative statistical methods that continue to shape modern healthcare. His leadership in key genetics projects over the past two decades has driven major advances in the field, profoundly impacting healthcare systems and patient outcomes.

The 2025 CPM Annual Lecture was given by Philip Ball, at the Sheldonian Theatre, Oxford, on Thursday 13th February. Philip Ball is a freelance writer and broadcaster, and was an editor at Nature for more than twenty years. He writes regularly in the scientific and popular media and has written many books on the interactions of the sciences, the arts, and wider culture, including H2O: A Biography of Water, Bright Earth: The Invention of Colour, The Music Instinct, and How Life Works. His book Critical Mass won the 2005 Aventis Prize for Science Books. Philip was the 2022 recipient of the Royal Society’s Wilkins-Bernal-Medawar Medal for contributions to the history, philosophy or social roles of science. He trained as a chemist at the University of Oxford and as a physicist at the University of Bristol.

The 2025 CPM Annual Lecture was given by Philip Ball, at the Sheldonian Theatre, Oxford, on Thursday 13th February. Philip Ball is a freelance writer and broadcaster, and was an editor at Nature for more than twenty years. He writes regularly in the scientific and popular media and has written many books on the interactions of the sciences, the arts, and wider culture, including H2O: A Biography of Water, Bright Earth: The Invention of Colour, The Music Instinct, and How Life Works. His book Critical Mass won the 2005 Aventis Prize for Science Books. Philip was the 2022 recipient of the Royal Society’s Wilkins-Bernal-Medawar Medal for contributions to the history, philosophy or social roles of science. He trained as a chemist at the University of Oxford and as a physicist at the University of Bristol.

Developments in whole genome sequencing technologies have catalysed incredible progress in the diagnosis of rare disease and the discovery of novel disease-associated genes. However, large-scale sequencing of population cohorts has revealed that many healthy individuals carry the same disease-causing variants as patients. The extent of this incomplete penetrance in individuals not ascertained on the basis of a family history or clinical diagnosis is neither well understood nor widely appreciated. In this talk, Professor Caroline Wright, Professor of Genomic Medicine at the Department of Clinical and Biomedical Sciences at the University of Exeter, outlines recent research into penetrance of different diseases across different populations, and discusses the broader implications of these findings for genomic screening. This is the 2024 Dr Stanley Ho Memorial Lecture, in collaboration with the Oxford Martin School, and it took place on 29 May 2024.

Developments in whole genome sequencing technologies have catalysed incredible progress in the diagnosis of rare disease and the discovery of novel disease-associated genes. However, large-scale sequencing of population cohorts has revealed that many healthy individuals carry the same disease-causing variants as patients. The extent of this incomplete penetrance in individuals not ascertained on the basis of a family history or clinical diagnosis is neither well understood nor widely appreciated. In this talk, Professor Caroline Wright, Professor of Genomic Medicine at the Department of Clinical and Biomedical Sciences at the University of Exeter, outlines recent research into penetrance of different diseases across different populations, and discusses the broader implications of these findings for genomic screening. This is the 2024 Dr Stanley Ho Memorial Lecture, in collaboration with the Oxford Martin School, and it took place on 29 May 2024.